On This Page

Filter

These are the filters currently being used to limit the search results. Click on the
icon to remove the filter.

max date

2019-01-29

answer › answering member printed

Norman Lamb

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are
shown at the top of the list. Click on to remove a sort and or to reverse the current sort order. Click on the icon to remove all the sorting. Note that sorting can significantly slow down the
loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined
views, but starred properties are always present no matter what the view. You can
star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

To ask the Secretary of State for Health, what monies have been set aside to fund
litigation proceedings launched by independent practitioners in response to the recently
acknowledged failings of the Care Quality Commission's Intelligent Monitoring methodology.

<p>The Care Quality Commission (CQC) is the independent regulator of health and adult
social care in England. As the CQC is responsible for developing its own methodology
for assessing whether providers are meeting the registration requirements, the CQC
would be responsible for any legal proceedings that arose in relation to that methodology.</p><p>
</p><p> </p><p> </p><p>The CQC has advised that it will deal with any legal proceedings
that may be brought against it. It has made no specific arrangements, as each case
must be reviewed on its merits.</p><p> </p><p><strong> </strong></p><p> </p><p><strong>
</strong></p><p> </p><p><strong> </strong></p><p> </p>

To ask the Secretary of State for Health, what assessment his Department has made
of the role independent pharmacies play in relieving pressures on other health and
welfare services; and what steps he has taken to disseminate best practice.

<p>Pharmacy already plays a vital role in supporting the health of people in their
local communities, providing high quality care and support, improving people's health
and reducing health inequalities. However, as we move to more integrated care, there
is real potential for pharmacists and their teams to play an even greater role in
the future, particularly in keeping people healthy, supporting those with long term
conditions and helping make sure patients and the National Health Service get the
best use from medicines.</p><p> </p><p>NHS England's public consultation, <em>Improving
care through community pharmacy –</em> <em>a call to action</em>, which closed on
18 March, has provided an important opportunity to explore the contribution community
pharmacists and their teams can make. This will inform a strategic framework for commissioning
wider primary care services in the autumn. A copy of the consultation document is
at:</p><p> </p><p>www.england.nhs.uk/ourwork/qual-clin-lead/calltoaction/pharm-cta/</p><p>
</p><p>In the meantime, NHS England's <em>The earlier, the better</em> campaign, launched
in January 2014, specifically sought to raise the profile of community pharmacy with
the public, to increase the number of people accessing community pharmacy services
when they have a minor ailment and reduce pressures on other parts of the NHS.</p><p>
</p><p>On 14 April, the Department and NHS England published <em>Transforming Primary
Care - Safe, proactive, personalised care for those who need it most</em>. This sets
out plans for more proactive, personalised and joined up care, part of which is harnessing
the potential of pharmacists. This recognises the vital role that pharmacists have
in optimising medicines use, helping to prevent avoidable hospital admissions and
supporting people to manage their own care. A copy has been placed in the Library.</p><p>
</p>

<p>The International Classification of Diseases is the standard diagnostic tool for
epidemiology, health management and clinical purposes. This includes the analysis
of the general health situation of population groups. It is used to monitor the incidence
and prevalence of diseases and other health problems.</p><p>The Tenth Revision of
the International Statistical Classification of Diseases and Related Health Problems
includes in Chapter V a detailed classification of more than 300 mental and behavioural
disorders. Its publication follows extensive field-testing by more than 100 clinical
and research centres in 40 countries.</p><p>Aggregate primary care trust (PCT) expenditure
on mental health was £11.28 billion in 2012-13, which is 11.9% of the £94.78 billion
total spend by PCTs. The estimate of expenditure on mental health does not include
the majority of expenditure on primary care appointments which is recorded as a separate
programme category.</p><p> </p><p>It is not possible to provide an estimate of expenditure
on physical health. A number of programme categories will have elements of expenditure
which could be classified as non-physical, for example, learning disabilities, neurological
and social care.</p><p> </p><p>The Department has made no estimate of the cost to
the economy of untreated mental illness.</p><p> </p><p> </p>

<p>The International Classification of Diseases is the standard diagnostic tool for
epidemiology, health management and clinical purposes. This includes the analysis
of the general health situation of population groups. It is used to monitor the incidence
and prevalence of diseases and other health problems.</p><p>The Tenth Revision of
the International Statistical Classification of Diseases and Related Health Problems
includes in Chapter V a detailed classification of more than 300 mental and behavioural
disorders. Its publication follows extensive field-testing by more than 100 clinical
and research centres in 40 countries.</p><p>Aggregate primary care trust (PCT) expenditure
on mental health was £11.28 billion in 2012-13, which is 11.9% of the £94.78 billion
total spend by PCTs. The estimate of expenditure on mental health does not include
the majority of expenditure on primary care appointments which is recorded as a separate
programme category.</p><p> </p><p>It is not possible to provide an estimate of expenditure
on physical health. A number of programme categories will have elements of expenditure
which could be classified as non-physical, for example, learning disabilities, neurological
and social care.</p><p> </p><p>The Department has made no estimate of the cost to
the economy of untreated mental illness.</p><p> </p><p> </p>

<p>Pharmacy already plays a vital role in supporting the health of people in their
local communities, providing high quality care and support, improving people's health
and reducing health inequalities. However, as we move to more integrated care, there
is real potential for pharmacists and their teams to play an even greater role in
the future, particularly in keeping people healthy, supporting those with long term
conditions and helping make sure patients and the National Health Service get the
best use from medicines.</p><p> </p><p>NHS England's public consultation, <em>Improving
care through community pharmacy –</em> <em>a call to action</em>, which closed on
18 March, has provided an important opportunity to explore the contribution community
pharmacists and their teams can make. This will inform a strategic framework for commissioning
wider primary care services in the autumn. A copy of the consultation document is
at:</p><p> </p><p>www.england.nhs.uk/ourwork/qual-clin-lead/calltoaction/pharm-cta/</p><p>
</p><p>In the meantime, NHS England's <em>The earlier, the better</em> campaign, launched
in January 2014, specifically sought to raise the profile of community pharmacy with
the public, to increase the number of people accessing community pharmacy services
when they have a minor ailment and reduce pressures on other parts of the NHS.</p><p>
</p><p>On 14 April, the Department and NHS England published <em>Transforming Primary
Care - Safe, proactive, personalised care for those who need it most</em>. This sets
out plans for more proactive, personalised and joined up care, part of which is harnessing
the potential of pharmacists. This recognises the vital role that pharmacists have
in optimising medicines use, helping to prevent avoidable hospital admissions and
supporting people to manage their own care. A copy has been placed in the Library.</p><p>
</p>

<p>The International Classification of Diseases is the standard diagnostic tool for
epidemiology, health management and clinical purposes. This includes the analysis
of the general health situation of population groups. It is used to monitor the incidence
and prevalence of diseases and other health problems.</p><p>The Tenth Revision of
the International Statistical Classification of Diseases and Related Health Problems
includes in Chapter V a detailed classification of more than 300 mental and behavioural
disorders. Its publication follows extensive field-testing by more than 100 clinical
and research centres in 40 countries.</p><p>Aggregate primary care trust (PCT) expenditure
on mental health was £11.28 billion in 2012-13, which is 11.9% of the £94.78 billion
total spend by PCTs. The estimate of expenditure on mental health does not include
the majority of expenditure on primary care appointments which is recorded as a separate
programme category.</p><p> </p><p>It is not possible to provide an estimate of expenditure
on physical health. A number of programme categories will have elements of expenditure
which could be classified as non-physical, for example, learning disabilities, neurological
and social care.</p><p> </p><p>The Department has made no estimate of the cost to
the economy of untreated mental illness.</p><p> </p><p> </p>

<p>The Department has made no such assessment.</p><p> </p><p>The National Institute
for Health and Care Excellence (NICE) and the National Patient Safety Agency (NPSA)
issued joint guidance, <em>Technical patient safety solutions for medicines reconciliation
on admission of adults to hospital</em> in December 2007, which aims to reduce medication
errors, which occur most commonly on transfer between care settings and on admission
to hospital. This guidance applies to all patients, including those with Parkinson's
disease and is available at:</p><p> </p><p>www.nice.org.uk/nicemedia/live/11897/38560/38560.pdf</p><p>
</p><p>The NPSA also issued a Rapid Response Report on <em>Reducing harm from omitted
and delayed medicines in hospital </em>in February 2010. This makes reference to medicines
where timeliness of administration is crucial, including those for Parkinson's disease.
This is available at:</p><p> </p><p>www.nrls.npsa.nhs.uk/alerts/?entryid45=66720</p><p>
</p><p>NICE, the NPSA and the Royal Pharmaceutical Society have all identified the
key role of pharmacists in medicines reconciliation and the majority of hospitals
now have pharmacists on admission wards to help ensure patients' medicines are reconciled
promptly.</p><p> </p><p>A strong reporting culture, where safety incidents are reported
and monitored is essential to improving safety for all patients, including those with
Parkinson's disease. NHS England and the <a title="Medicines and Healthcare products
Regulatory Agency (MHRA) website - Opens in a new window" href="http://www.mhra.gov.uk/"
target="_blank">Medicines and Healthcare products Regulatory Agency</a> jointly issued
two patient safety alerts on 20 March 2014 to help healthcare providers increase incident
reporting for <a href="http://www.england.nhs.uk/2014/03/20/med-devices#mederr" target="_blank">medication
errors</a> and <a href="http://www.england.nhs.uk/2014/03/20/med-devices#meddev" target="_blank">medical
devices</a>. The alerts instruct providers to take specific steps that will improve
data reporting quality; and will see the establishment of national networks to maximise
learning and provide guidance on minimising harm relating to these incident types.</p><p>
</p><p>The measures announced by my Rt Hon Friend, the Secretary of State for Health
on 26 March, as part of his invitation to NHS organisations to ‘Sign up to Safety',
are also likely to lead to an increase in the number of reported incidents of harm
in the National Health Service even though care will be getting safer.</p><p> </p>

To ask the Secretary of State for Health, what steps he is taking to improve reporting
of instances in which the medication regimes of hospital patients with Parkinson's
are disrupted through delays or errors in medicines reconciliation; and if he will
make a statement.

<p>The Department has made no such assessment.</p><p> </p><p>The National Institute
for Health and Care Excellence (NICE) and the National Patient Safety Agency (NPSA)
issued joint guidance, <em>Technical patient safety solutions for medicines reconciliation
on admission of adults to hospital</em> in December 2007, which aims to reduce medication
errors, which occur most commonly on transfer between care settings and on admission
to hospital. This guidance applies to all patients, including those with Parkinson's
disease and is available at:</p><p> </p><p>www.nice.org.uk/nicemedia/live/11897/38560/38560.pdf</p><p>
</p><p>The NPSA also issued a Rapid Response Report on <em>Reducing harm from omitted
and delayed medicines in hospital </em>in February 2010. This makes reference to medicines
where timeliness of administration is crucial, including those for Parkinson's disease.
This is available at:</p><p> </p><p>www.nrls.npsa.nhs.uk/alerts/?entryid45=66720</p><p>
</p><p>NICE, the NPSA and the Royal Pharmaceutical Society have all identified the
key role of pharmacists in medicines reconciliation and the majority of hospitals
now have pharmacists on admission wards to help ensure patients' medicines are reconciled
promptly.</p><p> </p><p>A strong reporting culture, where safety incidents are reported
and monitored is essential to improving safety for all patients, including those with
Parkinson's disease. NHS England and the <a title="Medicines and Healthcare products
Regulatory Agency (MHRA) website - Opens in a new window" href="http://www.mhra.gov.uk/"
target="_blank">Medicines and Healthcare products Regulatory Agency</a> jointly issued
two patient safety alerts on 20 March 2014 to help healthcare providers increase incident
reporting for <a href="http://www.england.nhs.uk/2014/03/20/med-devices#mederr" target="_blank">medication
errors</a> and <a href="http://www.england.nhs.uk/2014/03/20/med-devices#meddev" target="_blank">medical
devices</a>. The alerts instruct providers to take specific steps that will improve
data reporting quality; and will see the establishment of national networks to maximise
learning and provide guidance on minimising harm relating to these incident types.</p><p>
</p><p>The measures announced by my Rt Hon Friend, the Secretary of State for Health
on 26 March, as part of his invitation to NHS organisations to ‘Sign up to Safety',
are also likely to lead to an increase in the number of reported incidents of harm
in the National Health Service even though care will be getting safer.</p><p> </p>

To ask the Secretary of State for Health, what discussions officials in his Department
have had with the National Institute for Health and Care Excellence (NICE) on the
development of NICE's highly specialised technologies programme since 1 January 2014;
what the content of those discussions was; and if he will make a statement.

<p>Departmental officials have had no such discussions. Officials may discuss individual
highly specialised technology topics with the National Institute for Health and Care
Excellence, including at the topic selection stage.</p>

To ask the Secretary of State for Health, what estimate his Department has made of
the increase in demand for child and adolescent mental health following the launch
of the MindEd e-portal; and what steps it is taking to accommodate that increase.

<p>The Department has not made an estimate of the increase in demand for child and
adolescent mental health following the launch of the MindEd e-portal on 25 March 2014.</p><p>
</p><p>We know that many schools want to do more to help children who are, or may
be, experiencing mental health problems. Many now have their own programmes and mental
health support – such as a school-based counsellor, whilst others have whole school
approaches to mental and emotional health. We want to ensure that such programmes
offer the best support possible, but also that schools are better able to identify
mental health problems in their pupils sooner.</p><p> </p><p>The Department funded
the MindEd website which will help anyone working with children, including all school
staff, to spot the signs of mental health problems in children and help them get the
support they need. Spotting the signs of mental health problems early in children
and young people is essential to prevent problems from escalating and continuing into
adulthood.</p><p> </p><p>The Chief Medical Officer has recommended better data on
children and young people's mental health. The Department, with arms lengths bodies
(ALBs) and other key partners, is currently looking at the options available for arranging
a survey of children and young people to look at prevalence of mental health conditions.
We are seeking advice from colleagues in the Department's Health and Social Care Information
Centre to consider options for the survey, and what such a survey would be able to
tell us.</p><p> </p>